A team of bioengineers and physicians at the University of California San Diego(La Jolla,CA,USA;www.ucsd.edu) has developed a new biomaterial that can be injected intravenously to reduce inflammation in tissue and encourage cell and tissue repair.

Researchers who developed the biomaterial also tested it and proved its effectiveness in treating tissue damage as a result of heart attacks in rodent as well as large animal models.

They also provided proof of concept in a rodent model that the biomaterial may benefit patients with traumatic brain injury and pulmonary arterial hypertension.